Citadel Advisors’s CapForce IBD Breakout Opportunities ETF BOUT Stock Holding History
Bought
Maintained
Sold
Other funds holding BOUT
CWM
CMMS
MMCM
ADL
HCM
IA
DFA
FFA
Citadel Advisors's BOUT Position: Q2 2026 in Review
Citadel Advisors reduced its CapForce IBD Breakout Opportunities ETF (BOUT) stake by 11% in Q2 2026, selling an estimated $102K and leaving 18,396 shares worth $900K. The position accounts for ﹤0.01% of the portfolio, ranked #8462.
Citadel Advisors first reported a position in BOUT in Q4 2018 and has held it in 19 quarters since. The position peaked at $1.41M in Q4 2024. 12 funds tracked by Wall St. Rank hold BOUT as of Q2 2026.
- Citadel Advisors held 18,396 shares of CapForce IBD Breakout Opportunities ETF worth $900K as of Q2 2026.
- Citadel Advisors sold 2,253 CapForce IBD Breakout Opportunities ETF shares in Q2 2026, an estimated $102K.
- CapForce IBD Breakout Opportunities ETF made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #8462 holding.
- Citadel Advisors first reported a position in CapForce IBD Breakout Opportunities ETF in Q4 2018 and has held it in 19 quarters since.
- Citadel Advisors's CapForce IBD Breakout Opportunities ETF position peaked at $1.41M in Q4 2024.
- 12 funds tracked by Wall St. Rank held CapForce IBD Breakout Opportunities ETF as of Q2 2026.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.